Banner Image

Join the conversation—What Transparency Means to Me

Join Our Mission—Take the Transparency Pledge

New MPIP Guidance on Adverse Event Reporting Now Available  

Twitter icon LinkedIn icon

Latest Initiative


Transparency and Data Sharing Blog

Do you have a role in transparent data reporting for industry-sponsored research? Visit the Transparency and Data Sharing Blog today for insights from industry experts!

This month Darren Taichman, Secretary of ICMJE and Executive Deputy Editor of Annals of Internal Medicine, provides clarification on the recent ICMJE data sharing statement.

Learn More

Stay in the Loop


Enter your email address below and select "Sign me up" to receive updates on MPIP initiatives.

 

Featured Publication


Recommendations to Improve Adverse Event Reporting in Clinical Trial Publications: A Joint Pharmaceutical Industry/Journal Editor Perspective, published in The BMJ in October 2016, provides guidance on clinically relevant and more informative adverse event reporting, to improve patient care and increase the credibility of industry-sponsored publications.

Learn More

Transparency Matters


MPIP has created a global educational platform and call to action—Transparency Matters—where authors, life-science companies, journal editors, and other interested parties can find published MPIP research, tools, and recommendations to help improve the level of transparency when reporting the results of industry-sponsored research.

Learn More

Best Practice Recommendations


MPIP co-sponsors collaborated with journal editors to develop best practice recommendations to improve reporting of drug adverse events in industry-sponsored clinical trial publications.

Learn More

Journal Editor Survey


A recent MPIP survey benchmarked journal editor perceptions regarding change in transparency and credibility of industry-sponsored clinical trial publications in the past 5 years.

Learn More

What Transparency Means to Me


Do you believe that reporting of industry-sponsored research in peer-reviewed journals should be transparent, balanced, and timely? Do you believe that ensuring transparency in medical communications represents an ethical imperative? Let your voice be heard, and tell us what transparency means to you!

Learn More

Journals Accepting Specialized Data


Many journals accept specialized data that are especially important when it comes to transparency. We've assembled a fairly comprehensive, searchable list that can be used to identify journals that align with your manuscript content for a variety of atypical scenarios.

Learn more

Now you can identify the right journal for data that are

  • Negative or neutral
  • In need of a rapid review
  • Presented in a case study or other special interest format
  • In need of continuing medical education accreditation
  • To be described as a dataset for reuse
  • From computer modeling

Why MPIP?


Medical Publishing Insights & Practices (MPIP) was founded in 2008 by members of the pharmaceutical industry and the International Society for Medical Publication Professionals (ISMPP) to elevate trust, transparency, and integrity in reporting the results of industry-sponsored research. The major goal of MPIP is to encourage more effective partnership between trial sponsors and medical journals to raise standards in medical publications and expand access to research results.

Learn more about MPIP

 

Privacy Policy | Contact Us
Copyright © 2011-2016 MPIP. All Rights Reserved.